National Health Ownership
| NHI Stock | USD 69.32 0.06 0.09% |
Shares in Circulation | First Issued 1991-03-31 | Previous Quarter 43.6 M | Current Value 44 M | Avarage Shares Outstanding 29.3 M | Quarterly Volatility 10.3 M |
National |
National Stock Ownership Analysis
About 68.0% of the company shares are owned by institutional investors. The book value of National Health was now reported as 33.73. The company has Price/Earnings To Growth (PEG) ratio of 1.99. National Health Investors last dividend was issued on the 31st of December 2024. is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHIs portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. National Health operates under REITHealthcare Facilities classification in the United States and is traded on New York Stock Exchange. It employs 19 people. To find out more about National Health Investors contact Eric Mendelsohn at 615 890 9100 or learn more at https://www.nhireit.com.Besides selling stocks to institutional investors, National Health also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different National Health's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align National Health's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
National Health Quarterly Liabilities And Stockholders Equity |
|
National Health Insider Trades History
About 5.0% of National Health Investors are currently held by insiders. Unlike National Health's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against National Health's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of National Health's insider trades
National Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as National Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading National Health Investors backward and forwards among themselves. National Health's institutional investor refers to the entity that pools money to purchase National Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Northern Trust Corp | 2024-09-30 | 512 K | Bank Of New York Mellon Corp | 2024-09-30 | 503.7 K | Sumitomo Mitsui Trust Group Inc | 2024-09-30 | 461.1 K | Prudential Financial Inc | 2024-09-30 | 421.4 K | Mirae Asset Global Etfs Holdings Ltd. | 2024-09-30 | 379.7 K | Gw&k Investment Management, Llc | 2024-09-30 | 340.8 K | Zimmer Partners Lp | 2024-09-30 | 300 K | Nuveen Asset Management, Llc | 2024-09-30 | 290.9 K | Centersquare Investment Management Llc | 2024-09-30 | 290.2 K | Vanguard Group Inc | 2024-09-30 | 6.3 M | Blackrock Inc | 2024-09-30 | 4.5 M |
National Health Investors Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific National Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on National Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases National Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
National Health Outstanding Bonds
National Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. National Health Investors uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most National bonds can be classified according to their maturity, which is the date when National Health Investors has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| NHI 3 01 FEB 31 Corp BondUS63633DAF15 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
National Health Corporate Filings
8K | 8th of January 2025 An amendment to a previously filed Form 8-K | ViewVerify |
F3 | 3rd of January 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
8K | 2nd of December 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 5th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Dividend Share 3.6 | Earnings Share 2.91 | Revenue Per Share | Quarterly Revenue Growth (0.12) |
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.